Whole-Body Cholesterol Transport [Part 1/2] | Chylomicrons & VLDL

Main ideas and lessons

• Cholesterol and other lipids require special transport in blood because they are hydrophobic/insoluble, unlike sugars and amino acids, which are hydrophilic/polar/charged and dissolve well in blood.
• Lipoproteins solve this transport problem by having:
  • A polar (hydrophilic) outer surface that faces the blood/water
  • A nonpolar (hydrophobic) core that houses lipids like triglycerides and cholesterol
• Amphipathic molecules (e.g., phospholipids) make lipoproteins work:
  • Polar heads face outward toward blood
  • Hydrophobic tails face inward toward lipids

---

Step-by-step process: whole-body cholesterol/lipid transport (chylomicrons → VLDL → IDL → LDL)

1) From diet to chylomicrons (intestinal packaging)

• Diet provides lipids: triglycerides, fatty acids, and cholesterol.
• Lipids are absorbed through the GI tract, especially the jejunum.
• Absorbed lipids enter enterocytes (intestinal cells).
• Enterocytes package them into chylomicrons.
  • Chylomicrons are lipoproteins that transport dietary fats.
  • In chylomicrons, cholesterol is mostly in the form of cholesterol esters (explicitly: cholesterol ester forms are used).
  • Dietary fats are reassigned into triglycerides, rather than initially transported as free fatty acids.

2) Chylomicron delivery to peripheral tissues (lipoprotein lipase action)

• Chylomicrons enter the blood and deliver an initial “sweep” of lipids, especially free fatty acids.
• Delivery occurs to peripheral tissues, including:
  • Adipose tissue
    • Stores fatty acids as triglycerides (described as lipogenesis)
  • Skeletal muscle
    • Uses free fatty acids for energy production
• Key mechanism:
  • Cells that need free fatty acids activate lipoprotein lipase (LPL).
  • LPL hydrolyzes triglycerides in chylomicrons, releasing free fatty acids for cellular uptake.

3) Chylomicron remnant formation and return to the liver

• After triglyceride removal, chylomicrons become chylomicron remnants.
• Chylomicron remnants travel to the liver.
• Liver cell membrane remnant receptors bind the remnants.
• The liver endocytoses the remnants.
• The liver then repackages remaining lipids into a new lipoprotein: VLDL.

4) VLDL (liver release) and delivery like chylomicrons

• VLDL = very low-density lipoproteins, released by the liver.
• Composition differences vs chylomicrons:
  • Lower triglyceride proportion (given: ~52% triglycerides)
  • Higher cholesterol proportion (given split as cholesterol esters and free cholesterol, totaling a stated higher combined cholesterol percentage)
  • Contains phospholipids
• VLDL function:
  • Delivers free fatty acids to peripheral tissues.
• Mechanism:
  • Peripheral tissues use/contain lipoprotein lipase (LPL) activity to hydrolyze VLDL triglycerides, releasing free fatty acids for:
    • energy use (skeletal muscle)
    • storage (adipose tissue)

5) VLDL → IDL → LDL conversion logic (by triglyceride loss)

• As VLDLs lose triglycerides through LPL activity, they become:
  • IDL = intermediate-density lipoprotein
• IDL then returns to the liver and interacts with hepatic lipase.
  • Hepatic lipase converts IDL into LDL.
• Percentage trend described:
  • As triglyceride percentages decrease, cholesterol percentages increase by proportion.
  • LDL’s higher cholesterol fraction is attributed to loss of triglycerides, not “gaining” cholesterol.

6) Important LDL release lesson (not directly released by the liver)

LDL is not directly released by the liver.

• Correct pathway emphasized:
  • The liver releases VLDL
  • VLDL → IDL
  • IDL returns to the liver and is converted into LDL
• Therefore, LDL arises from two successive precursor steps, not direct secretion.

---

Speaker / sources featured

• Kevin Tokeff (host/speaker; introduced as “my name is Kevin toke off”)
• Catalyst University (channel/series referenced in the introduction)